Clarivate Plc has released its 2024 Drugs to Watch report, highlighting 13 potential therapeutics believed to transform healthcare in the following year. The drugs cover a variety of conditions, from sickle cell anemia to AMD. The report also emphasizes the growing influence of technologies such as CRISPR-Cas9 gene editing and AI/ML in drug development, potentially expediting innovation and the delivery of life-saving therapies.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
